Encompass Health (EHC) Cost of Revenue (2009 - 2026)

Encompass Health has reported Cost of Revenue for 18 years, with the latest figure at $241.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 11.22% year-over-year to $241.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 51.3% YoY), and the FY2025 full-year result was $888.7 million, up 10.73% from the prior year.
• Cost of Revenue for Q1 2026 stood at $241.9 million, down from $698.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $698.8 million in Q4 2025, with the low at -$316.0 million in Q4 2023.
• Historically, Cost of Revenue has averaged $190.0 million across 5 years, with a median of $183.7 million in 2023.
• Annual changes were most pronounced in 2023 — Cost of Revenue sank 160.51% — and 2025, when it soared 271.79%.
• Encompass Health's Cost of Revenue stood at $522.2 million in 2022, then slumped by 160.51% to -$316.0 million in 2023, then jumped by 165.32% to $206.4 million in 2024, then surged by 238.57% to $698.8 million in 2025, then tumbled by 65.38% to $241.9 million in 2026.
• The last three Cost of Revenue figures came in at $241.9 million (Q1 2026), $698.8 million (Q4 2025), and $231.1 million (Q3 2025), per Business Quant data.